Model-based and model-free parametric analysis of Breast dynamic-contrast-enhanced MRI

NMR in Biomedicine

Volumn 22, Issue 1, 2009, Pages 40-53

  Eyal, Erez ^a   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Breast; Cancer; Dynamic contrast enhancement; Kinetic analysis; Machine learning methods; MRI; Unsupervised methods

Indexed keywords

BREAST; CANCER; DYNAMIC CONTRAST ENHANCEMENT; KINETIC ANALYSIS; MACHINE LEARNING METHODS; MRI; UNSUPERVISED METHODS;

GADOLINIUM; IMAGE PROCESSING; LIGHT MEASUREMENT; MATHEMATICAL MODELS; ROBOT LEARNING;

PHYSIOLOGICAL MODELS;

BODY DISTRIBUTION; BREAST CANCER; CONTRAST ENHANCEMENT; DYNAMIC CONTRAST ENHACED MAGNETIC RESONANCE IMAGING; FUZZY SYSTEM; GENE SEQUENCE; HUMAN; INTERMETHOD COMPARISON; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REVIEW; TISSUE PERFUSION; TISSUE SPECIFICITY;

BREAST; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL;

EID: 65349098099     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1221     Document Type: Review

References (101)

1. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989; 170: 681-686.
2. Hylton N. MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn. Reson. Imaging Clin. N. Am. 2006; 14: 383-389, vii.
3. Furman-Haran E, Degani H. Parametric analysis of breast MRI. J. Comput. Assist. Tomogr. 2002; 26: 376-386.
4. Schnall MD. An overview of interpretation strategies for breast MR imaging. Magn. Reson. Imaging Clin. N. Am. 2001; 9: 289-294.
5. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001; 220: 13-30.
6. Leach MO. Application of magnetic resonance imaging to angiogenesis in breast cancer. Breast Cancer Res. 2001; 3: 22-27.
7. Kuhl CK, Schild HH. Dynamic image interpretation of MRI of the breast. J. Magn. Reson. Imaging 2000; 12: 965-974.
8. Helbich TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur. J. Radiol. 2000; 34: 208-219.
9. Ikeda O, Yamashita Y, Takahashi M. Gd-enhanced dynamic magnetic resonance imaging of breast masses. Top. Magn. Reson. Imaging 1999; 10: 143-151.
10. Viehweg P, Paprosch I, Strassinopoulou M, Heywang-Kobrunner SH. Contrast-enhanced magnetic resonance imaging of the breast: interpretation guidelines. Top. Magn. Reson. Imaging 1998; 9: 17-43.
11. Collins DJ, Padhani AR. Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges. IEEE Eng. Med. Biol. Mag. 2004; 23: 65-83.
12. Solomon I, Bloembergen N. Nuclear magnetic interactions in the HF molecule. J. Chem. Phys. 1956; 25: 261-266.
13. Zimmerman J, Brittin W. Nuclear magnetic resonance studies in multiple phase systems: lifetime of a water molecule in an adsorbing phase on silica gel. J. Phys. Chem. 1957; 64: 1328-1336.
14. Woessner D. Nuclear transfer effects in Nuclear magnetic resonance pulse experiments. J. Chem. Phys. 1961; 35: 41-51.
15. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn. Reson. Med. 1994; 32: 66-76.
16. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. J. Magn. Reson. Imaging 1997; 7: 102-110.
17. Judd RM, Reeder SB, May-Newman K. Effects of water exchange on the measurement of myocardial perfusion using paramagnetic contrast agents. Magn. Reson. Med. 1999; 41: 334-342.
18. Larsson HB, Rosenbaum S, Fritz-Hansen T. Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart. Magn. Reson. Med. 2001; 46: 272-281.
19. Buckley DL. Letter to the editor: Transcytolemal Water Exchange and its effect on the determination of contrast agent concentration in vivo. Magn. Reson. Med. 2002; 47: 420-421.
20. Landis CS, Li X, Telang FW, Coderre JA, Micca PL, Rooney WD, Latour LL, Vetek G, Palyka I, Springer CS Jr. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn. Reson. Med. 2000; 44: 563-574.
21. Kim YR, Rebro KJ, Schmainda KM. Water exchange and inflow affect the accuracy of T1-GRE blood volume measurements: implications for the evaluation of tumor angiogenesis. Magn. Reson. Med. 2002; 47: 1110-1120.
22. Yankeelov TE, Rooney WD, Huang W, Dyke JP, Li X, Tudorica A, Lee JH, Koutcher JA, Springer CS Jr, Zhou R, Pickup S, Glickson JD. Evidence for shutter-speed variation in CR bolus tracking studies of human pathology. NMR Biomed. 2005; 18: 173-185.
23. Yankeelov TE, Rooney WD, Li X, Springer CS Jr. Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape. Magn. Reson. Med. 2003; 50: 1151-1169.
24. Li X, Rooney WD, Springer CS Jr. A unified magnetic resonance imaging pharmacokinetic theory: intravascular and extracellular contrast reagents. Magn. Reson. Med. 2005; 54: 1351-1359.
25. Dadiani M, Margalit R, Sela N, Degani H. High-resolution magnetic resonance imaging of disparities in the transcapillary transfer rates in orthotopically inoculated invasive breast tumors. Cancer Res. 2004; 64: 3155-3161.
26. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI-Transcytolemmal water exchange and its effect on the determination of contrast agent concentration in vivo. Magn. Reson. Med. 2002; 47: 601-606.
27. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging 1997; 7: 91-101.
28. Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 1951; 3: 1-41.
29. Patlak CS, Fenstermacher JD, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983; 3: 1-7.
30. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defects by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 1990; 16: 117-131.
31. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J. Comput. Assist. Tomogr. 1991; 15: 621-628.
32. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn. Reson. Med. 1991; 17: 357-367.
33. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Breast Imaging 1994; 2: 633-658.
34. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn. Reson. Med. 1995; 33: 564-568.
35. Mussurakis S, Buckley DL, Drew PJ, Fox JN, Carleton PJ, Turnbull LW, Horsman A, Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours. Clin. Radiol. 1997; 52: 516-526.
36. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 1999; 10: 223-232.
37. Kroll K, Wilke N, Jerosch-Herold M, Wang Y, Zhang Y, Bache RJ, Bassingthwaighte JB. Modeling regional myocardial flows from residue functions of an intravascular indicator. Am. J. Physiol. 1996; 271: H1643-H1655.
38. Brix G, Kiessling F, Lucht R, Darai S, Wasser K, Delorme S, Griebel J. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn. Reson. Med. 2004; 52: 420-429.
39. Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed. 2002; 15: 154-163.
40. Eliat PA, Dedieu V, Bertino C, Boute V, Lacroix J, Constans JM, de Korvin B, Vincent C, Bailly C, Joffre F, de Certaines J, Vincensini D. Magnetic resonance imaging contrast-enhanced relaxometry of breast tumors: an MRI multicenter investigation concerning 100 patients. Magn. Reson. Imaging 2004; 22: 475-481.
41. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol. Cancer Res. Treat 2006; 5: 401-410.
42. Vincensini D, Dedieu V, Eliat PA, Vincent C, Bailly C, de Certaines J, Joffre F. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry. Magn. Reson. Imaging 2007; 25: 293-302.
43. Furman-Haran E, Schechtman E, Kelcz F, Kirshenbaum K, Degani H. Magnetic resonance imaging reveals functional diversity of the vasculature in benign and malignant breast lesions. Cancer 2005; 104: 708-718.
44. Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987; 47: 3039-3051.
45. Jain RK, Baxter LT. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 1988; 48: 7022-7032.
46. Baxter LT, Jain RK. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res. 1989; 37: 77-104.
47. Netti PA, Roberge S, Boucher Y, Baxter LT, Jain RK. Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc. Res. 1996; 52: 27-46.
48. Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure: an obstacle in cancer therapy. Nat. Rev. Cancer 2004; 4: 806-813.
49. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 2001; 46: 149-168.
50. Hassid Y, Furman-Haran E, Margalit R, Eilam R, Degani H. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Res. 2006; 66: 4159-4166.
51. Zhao J, Salmon H, Sarntinoranont M. Effect of heterogeneous vasculature on interstitial transport within a solid tumor. Microvasc. Res. 2007; 73: 224-236.
52. Dadiani M, Kalchenko V, Yosepovich A, Margalit R, Hassid Y, Degani H, Seger D. Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer. Cancer Res. 2006; 66: 8037-8041.
53. Hassid Y, Margalit R, Eyal E, Furman-Haran E, Degani H. Mapping concentration and pressure dependent transfer constants in tumors by slow infusion DCE-MRI. Joint Annual Meeting ISMRM-ESMRMB, Berlin, Germany, 2007.
54. Jain RK, Tong RT, Munn LL. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res. 2007; 67: 2729-2735.
55. Knopp MV, Weiss E, Sinn HP, Mattern J, Junkermann H, Radeleff J, Magener A, Brix G, Delorme S, Zuna I, Kaick Gv. Pathophysiologic basis of contrast enhancement in breast tumors. J. Magn. Reson. Imaging 1999; 10: 260-266.
56. Buckley DL, Drew PJ, Mussurakis S, Monson JRT, Horsman A. Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J. Magn. Reson. Imaging 1997; 7: 461-464.
57. Ikeda O, Nishimura R, Miyayama H, Yasunaga T, Ozaki Y, Tuji A, Yamashita Y. Evaluation of tumor angiogenesis using dynamic enhanced magnetic resonance imaging: comparison of plasma vascular endothelial growth factor, hemodynamic, and pharmacokinetic parameters. Acta. Radiol. 2004; 45: 446-452.
58. Zhou R, Pickup S, Yankeelov TE, Springer CS Jr, Glickson JD. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn. Reson. Med. 2004; 52: 248-257.
59. Dadiani M, Furman-Haran E, Degani H. The application of NMR in tumor angiogenesis research. Progress in NMR Spectroscopy 2006; 49: 27-44.
60. Weinstein D, Strano S, Cohen P, Fields S, Gomori JM, Degani H. Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging: pilot study. Radiology 1999; 210: 233-240.
61. Landis CS, Li X, Telang FW, Molina PE, Palyka I, Vetek G, Springer CSJ. Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo. Magn. Reson. Med. 1999; 42: 467-478.
62. Fritz-Hansen T, Rostrup E, Larsson HBW, Sondergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step towards quantitative perfusion imaging. Magn. Reson. Med. 1996; 36: 225-231.
63. Zhu XP, Li KL, Kamaly-Asl ID, Checkley DR, Tessier JJ, Waterton JC, Jackson A. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging. J. Magn. Reson. Imaging 2000; 11: 575-585.
64. Ahearn TS, Staff RT, Redpath TW, Semple SI. The effects of renal variation upon measurements of perfusion and leakage volume in breast tumours. Phys. Med. Biol. 2004; 49: 2041-2051.
65. Schmid V, Whitcher B, Yang G. Semi-parametric analysis of dynamic contrast-enhanced MRI using Bayesian P-splines. MICCAI 2006; 9: 679-686.
66. Port RE, Knopp MV, Brix G. Dynamic contrast-enhanced MRI using Gd-DTPA: interindividual variability of the arterial input function and consequences for the assessment of kinetics in tumors. Magn. Reson. Med. 2001; 45: 1030-1038.
67. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn. Reson. Med. 2006; 56: 993-1000.
68. Hayton P, Brady M, Tarassenko L, Moore N. Analysis of dynamic MR breast images using a model of contrast enhancement. Med. Image Anal. 1997; 1: 207-224.
69. Tofts PS, Berkowitz BA. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn. Reson. Imaging 1994; 12: 81-91.
70. Horsfield MA, Morgan B. Algorithms for calculation of kinetic parameters from T1-weighted dynamic contrast-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 2004; 20: 723-729.
71. Ahearn TS, Staff RT, Redpath TW, Semple SI. The use of the Levenberg-Marquardt curve-fitting algorithm in pharmacokinetic modelling of DCE-MRI data. Phys. Med. Biol. 2005; 50: N85-92.
72. Schmid VJ, Whitcher B, Padhani AR, Taylor NJ, Yang GZ. Bayesian methods for pharmacokinetic models in dynamic contrast-enhanced magnetic resonance imaging. IEEE Trans. Med. Imaging 2006; 25: 1627-1636.
73. Degani H, Gusis V, Weinstein D, Fields S, Strano S. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat. Med. 1997; 3: 780-782.
74. Martel AL. A fast method of generating pharmacokinetic maps from dynamic contrast-enhanced images of the breast. Med. Image Comput. Assist. Interv. Int. Conf. 2006; 9: 101-108.
75. Kelcz F, Furman-Haran E, Grobgeld D, Degani H. Clinical testing of high-spatial-resolution parametric contrast-enhanced MR imaging of the breast. AJR Am. J. Roentgenol. 2002; 179: 1485-1492.
76. Hauth EA, Stockamp C, Maderwald S, Muhler A, Kimmig R, Jaeger H, Barkhausen J, Forsting M. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography. Clin. Imaging 2006; 30: 160-165.
77. Chou CP, Wu MT, Chang HT, Lo YS, Pan HB, Degani H, Furman-Haran E. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Acad. Radiol. 2007; 14: 561-573.
78. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn. Reson. Med. 1995; 33: 506-514.
79. Furman-Haran E, Grobgeld D, Kelcz F, Degani H. Critical role of spatial resolution in dynamic contrast-enhanced breast MRI. J. Magn. Reson. Imaging 2001; 13: 862-867.
80. Twellmann T, Saalbach A, Gerstung O, Leach MO, Nattkemper TW. Image fusion for dynamic contrast enhanced magnetic resonance imaging. Biomed. Eng. Online 2004; 3: 35.
81. Yoo SS, Gil Choi B, Han JY, Hee Kim H. Independent component analysis for the examination of dynamic contrast-enhanced breast magnetic resonance imaging data: preliminary study. Invest. Radiol. 2002; 37: 647-654.
82. Wismüller A, Lange O, Dersch DR, Leinsinger GL, Hahn K, Pütz B, Auer D. Cluster analysis of biomedical image time-series. International Journal of Computer Vision 2004; 46: 103-128.
83. Moate PJ, Dougherty L, Schnall MD, Landis RJ, Boston RC. A modified logistic model to describe gadolinium kinetics in breast tumors. Magn. Reson. Imaging 2004; 22: 467-473.
84. Twellmann T, Lichte O, Nattkemper TW. An adaptive tissue characterization network for model-free visualization of dynamic contrast-enhanced magnetic resonance image data. IEEE Trans. Med. Imaging 2005; 24: 1256-1266.
85. Nattkemper TW, Arnrich B, Lichte O, Timm W, Degenhard A, Pointon L, Hayes C, Leach MO. Evaluation of radiological features for breast tumour classification in clinical screening with machine learning methods. Artif. Intell. Med. 2005; 34: 129-139.
86. Eyal E, Bloch B, Furman-Haran E, Genega E, Dewolf W, Bubley G, Degani H, Rofsky NM, Lenkinski RE. Pattern and model based analysis of dynamic contrast enhanced prostate MRI data. Joint Annual Meeting ISMRM-ESMRMB, Berlin, Germany, 2007.
87. Lucht R, Delorme S, Brix G. Neural network-based segmentation of dynamic MR mammographic images. Magn. Reson. Imaging 2002; 20: 147-154.
88. Lucht RE, Knopp MV, Brix G. Classification of signal-time curves from dynamic MR mammography by neural networks. Magn. Reson. Imaging 2001; 19: 51-57.
89. Szabo BK, Wiberg MK, Bone B, Aspelin P. Application of artificial neural networks to the analysis of dynamic MR imaging features of the breast. Eur. Radiol. 2004; 14: 1217-1225.
90. Gibbs P, Turnbull L. Textural analysis of contrast-enhanced MR images of the breast. Magn. Reson. Med. 2003; 50: 92-98.
91. Woods BJ, Clymer BD, Kurc T, Heverhagen JT, Stevens R, Orsdemir A, Bulan O, Knopp MV. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data. J. Magn. Reson. Imaging 2007; 25: 495-501.
92. Meinel LA, Stolpen AH, Berbaum KS, Fajardo LL, Reinhardt JM. Breast MRI lesion classification: improved performance of human readers with a backpropagation neural network computer- aided diagnosis (CAD) system. J. Magn. Reson. Imaging 2007; 25: 89-95.
93. Frouin F, Bazin JP, Paola MD, Jolivet O, Paola RD. FAMIS: a software package for functional feature extraction from biomedical multidimensional images. Comput. Med. Imaging Graph 1992; 16: 81-91.
94. Frouge C, Guinebretiere JM, Contesso G, Paola RD, Blery M. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest. Radiol. 1994; 29: 1043-1049.
95. Zagdanski AM, Sigal R, Bosq J, Bazin JP, Vanel D, Paola RD. Factor analysis of medical image sequences in MR of head and neck tumors. Am. J. Neuroradiol. 1994; 15: 1359-1368.
96. Jolliffe IT. Principal Component Analysis. Springer-Verlag: New York, 1989.
97. Bell A, Sejnowski T. An information-maximization approach to blind separation and blind deconvolution. Neural Comput. 1995; 7: 1129-1159.
98. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J. Comput. Assist. Tomogr. 1991; 15: 621-628.
99. Chen W, Giger ML, Bick U, Newstead GM. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI. Med. Phys. 2006; 33: 2878-2887.
100. Neal R. Bayesian Learning for Neural Networks, Volume 118 in Lecture Notes in Statistics series. Springer: New York, 1996.
101. Haralick R, Dinstein I, Shanmugam K. Textural features for image classification. IEEE Trans. Syst. Man. Cybern. 1973; 3: 610-621.